Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression (Q61776046)
Jump to navigation
Jump to search
scientific article published on 13 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression |
scientific article published on 13 April 2011 |
Statements
Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression (English)
Robert J Harris
Richard E Clark
13 April 2011